Interferon-induced activation of dendritic cells and monocytes by yellow fever vaccination correlates with early antibody responses
- PMID: 40333758
- PMCID: PMC12088451
- DOI: 10.1073/pnas.2422236122
Interferon-induced activation of dendritic cells and monocytes by yellow fever vaccination correlates with early antibody responses
Abstract
Yellow fever vaccination provides long-lasting protection and is a unique model for studying the immune response to an acute RNA virus infection in humans. To elucidate the early innate immune events preceding the rapid generation of protective immunity, we performed transcriptome analysis of human blood dendritic cell (DC) and monocyte subpopulations before and 3, 7, 14, and 28 d after vaccination. We detected temporary upregulation of IFN-stimulated genes (ISG) in all DC and monocyte subsets on days 3 and 7 after vaccination as well as cell type-specific responses and response kinetics. Single-cell RNA sequencing revealed rapid appearance of activated DC and monocyte clusters dominated by ISGs, inflammatory chemokines, and genes involved in antigen processing and presentation. This was confirmed by flow cytometric analysis in a large cohort of vaccinees. We identified SIGLEC1/CD169 upregulation as a sensitive indicator of the transient IFN-induced activation state elicited in DCs and monocytes by YF17D vaccination correlating with early protective IgM antibody responses.
Keywords: dendritic cells; interferon; monocytes; vaccination; yellow fever virus.
Conflict of interest statement
Competing interests statement:The authors declare no competing interest.
Similar articles
-
Next generation yellow fever vaccine induces an equivalent immune and transcriptomic profile to the current vaccine: observations from a phase I randomised clinical trial.EBioMedicine. 2024 Oct;108:105332. doi: 10.1016/j.ebiom.2024.105332. Epub 2024 Sep 17. EBioMedicine. 2024. PMID: 39293214 Free PMC article. Clinical Trial.
-
Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.Emerg Microbes Infect. 2021 Dec;10(1):2279-2290. doi: 10.1080/22221751.2021.2008772. Emerg Microbes Infect. 2021. PMID: 34792431 Free PMC article.
-
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.J Clin Invest. 2014 Jul;124(7):3147-58. doi: 10.1172/JCI75429. Epub 2014 Jun 9. J Clin Invest. 2014. PMID: 24911151 Free PMC article. Clinical Trial.
-
Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D.Adv Exp Med Biol. 2007;590:43-53. doi: 10.1007/978-0-387-34814-8_3. Adv Exp Med Biol. 2007. PMID: 17191376 Review. No abstract available.
-
Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?Curr Opin Immunol. 2009 Jun;21(3):308-13. doi: 10.1016/j.coi.2009.05.018. Epub 2009 Jun 10. Curr Opin Immunol. 2009. PMID: 19520559 Review.
References
-
- Fuertes Marraco S. A., et al. , Long-lasting stem cell-like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination. Sci. Transl. Med. 7, 282ra248 (2015). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources